piperonyl butoxide has been researched along with Fatty Liver in 1 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, E | 1 |
| Messner, B | 1 |
| Berndt, J | 1 |
1 other study available for piperonyl butoxide and Fatty Liver
| Article | Year |
|---|---|
Two mechanisms of CCl4-induced fatty liver: lipid peroxidation or covalent binding studied in cultured rat hepatocytes.
Topics: Animals; Binding, Competitive; Carbon Tetrachloride; Cells, Cultured; Fatty Liver; Female; Lipid Per | 1987 |